Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice
<p>Abstract</p> <p>We recently demonstrated that <it>caspase</it>-3 is important for apoptosis during spontaneous involution of the corpus luteum (CL). These studies tested if prostaglandin F<sub>2α </sub>(PGF<sub>2α</sub>) or FAS regulated lutea...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-02-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.RBEj.com/content/1/1/15 |
id |
doaj-292be6d510e54f6f9e5cdd91311f252e |
---|---|
record_format |
Article |
spelling |
doaj-292be6d510e54f6f9e5cdd91311f252e2020-11-25T00:45:51ZengBMCReproductive Biology and Endocrinology1477-78272003-02-01111510.1186/1477-7827-1-15Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient miceFlavell Richard AGonçalves Paulo Bayard DMatikainen TiinaLynch Maureen PPru James KCarambula Silvia FTilly Jonathan LRueda Bo R<p>Abstract</p> <p>We recently demonstrated that <it>caspase</it>-3 is important for apoptosis during spontaneous involution of the corpus luteum (CL). These studies tested if prostaglandin F<sub>2α </sub>(PGF<sub>2α</sub>) or FAS regulated luteal regression, utilize a <it>caspase</it>-3 dependent pathway to execute luteal cell apoptosis, and if the two receptors work via independent or potentially shared intracellular signaling components/pathways to activate <it>caspase</it>-3. Wild-type (WT) or <it>caspase</it>-3 deficient female mice, 25–26 days old, were given 10 IU equine chorionic gonadotropin (eCG) intraperitoneally (IP) followed by 10 IU human chorionic gonadotropin (hCG) IP 46 h later to synchronize ovulation. The animals were then injected with IgG (2 micrograms, i.v.), the FAS-activating antibody Jo2 (2 micrograms, i.v.), or PGF<sub>2α </sub>(10 micrograms, i.p.) at 24 or 48 h post-ovulation. Ovaries from each group were collected 8 h later for assessment of active <it>caspase</it>-3 enzyme and apoptosis (measured by the TUNEL assay) in the CL. Regardless of genotype or treatment, CL in ovaries collected from mice injected 24 h after ovulation showed no evidence of active <it>caspase</it>-3 or apoptosis. However, PGF<sub>2α </sub>or Jo2 at 48 h post-ovulation and collected 8 h later induced <it>caspase</it>-3 activation in 13.2 ± 1.8% and 13.7 ± 2.2 % of the cells, respectively and resulted in 16.35 ± 0.7% (PGF<sub>2α</sub>) and 14.3 ± 2.5% TUNEL-positive cells when compared to 1.48 ± 0.8% of cells CL in IgG treated controls. In contrast, CL in ovaries collected from <it>caspase</it>-3 deficient mice whether treated with PGF<sub>2α </sub>, Jo2, or control IgG at 48 h post-ovulation showed little evidence of active <it>caspase</it>-3 or apoptosis. CL of WT mice treated with Jo2 at 48 h post-ovulation had an 8-fold increase in the activity of <it>caspase</it>-8, an activator of <it>caspase</it>-3 that is coupled to the FAS death receptor. Somewhat unexpectedly, however, treatment of WT mice with PGF<sub>2α </sub>at 48 h post-ovulation resulted in a 22-fold increase in <it>caspase</it>-8 activity in the CL, despite the fact that the receptor for PGF<sub>2α </sub>has not been shown to be directly coupled to <it>caspase</it>-8 recruitment and activation. We hypothesize that PGF<sub>2α </sub>initiates luteolysis <it>in vivo</it>, at least in part, by increasing the bioactivity or bioavailability of cytokines, such as FasL and that multiple endocrine factors work in concert to activate <it>caspase</it>-3-driven apoptosis during luteolysis.</p> http://www.RBEj.com/content/1/1/15 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Flavell Richard A Gonçalves Paulo Bayard D Matikainen Tiina Lynch Maureen P Pru James K Carambula Silvia F Tilly Jonathan L Rueda Bo R |
spellingShingle |
Flavell Richard A Gonçalves Paulo Bayard D Matikainen Tiina Lynch Maureen P Pru James K Carambula Silvia F Tilly Jonathan L Rueda Bo R Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice Reproductive Biology and Endocrinology |
author_facet |
Flavell Richard A Gonçalves Paulo Bayard D Matikainen Tiina Lynch Maureen P Pru James K Carambula Silvia F Tilly Jonathan L Rueda Bo R |
author_sort |
Flavell Richard A |
title |
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
title_short |
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
title_full |
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
title_fullStr |
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
title_full_unstemmed |
Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
title_sort |
prostaglandin f2alpha- and fas-activating antibody-induced regression of the corpus luteum involves <it>caspase</it>-8 and is defective in <it>caspase</it>-3 deficient mice |
publisher |
BMC |
series |
Reproductive Biology and Endocrinology |
issn |
1477-7827 |
publishDate |
2003-02-01 |
description |
<p>Abstract</p> <p>We recently demonstrated that <it>caspase</it>-3 is important for apoptosis during spontaneous involution of the corpus luteum (CL). These studies tested if prostaglandin F<sub>2α </sub>(PGF<sub>2α</sub>) or FAS regulated luteal regression, utilize a <it>caspase</it>-3 dependent pathway to execute luteal cell apoptosis, and if the two receptors work via independent or potentially shared intracellular signaling components/pathways to activate <it>caspase</it>-3. Wild-type (WT) or <it>caspase</it>-3 deficient female mice, 25–26 days old, were given 10 IU equine chorionic gonadotropin (eCG) intraperitoneally (IP) followed by 10 IU human chorionic gonadotropin (hCG) IP 46 h later to synchronize ovulation. The animals were then injected with IgG (2 micrograms, i.v.), the FAS-activating antibody Jo2 (2 micrograms, i.v.), or PGF<sub>2α </sub>(10 micrograms, i.p.) at 24 or 48 h post-ovulation. Ovaries from each group were collected 8 h later for assessment of active <it>caspase</it>-3 enzyme and apoptosis (measured by the TUNEL assay) in the CL. Regardless of genotype or treatment, CL in ovaries collected from mice injected 24 h after ovulation showed no evidence of active <it>caspase</it>-3 or apoptosis. However, PGF<sub>2α </sub>or Jo2 at 48 h post-ovulation and collected 8 h later induced <it>caspase</it>-3 activation in 13.2 ± 1.8% and 13.7 ± 2.2 % of the cells, respectively and resulted in 16.35 ± 0.7% (PGF<sub>2α</sub>) and 14.3 ± 2.5% TUNEL-positive cells when compared to 1.48 ± 0.8% of cells CL in IgG treated controls. In contrast, CL in ovaries collected from <it>caspase</it>-3 deficient mice whether treated with PGF<sub>2α </sub>, Jo2, or control IgG at 48 h post-ovulation showed little evidence of active <it>caspase</it>-3 or apoptosis. CL of WT mice treated with Jo2 at 48 h post-ovulation had an 8-fold increase in the activity of <it>caspase</it>-8, an activator of <it>caspase</it>-3 that is coupled to the FAS death receptor. Somewhat unexpectedly, however, treatment of WT mice with PGF<sub>2α </sub>at 48 h post-ovulation resulted in a 22-fold increase in <it>caspase</it>-8 activity in the CL, despite the fact that the receptor for PGF<sub>2α </sub>has not been shown to be directly coupled to <it>caspase</it>-8 recruitment and activation. We hypothesize that PGF<sub>2α </sub>initiates luteolysis <it>in vivo</it>, at least in part, by increasing the bioactivity or bioavailability of cytokines, such as FasL and that multiple endocrine factors work in concert to activate <it>caspase</it>-3-driven apoptosis during luteolysis.</p> |
url |
http://www.RBEj.com/content/1/1/15 |
work_keys_str_mv |
AT flavellricharda prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT goncalvespaulobayardd prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT matikainentiina prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT lynchmaureenp prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT prujamesk prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT carambulasilviaf prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT tillyjonathanl prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice AT ruedabor prostaglandinf2alphaandfasactivatingantibodyinducedregressionofthecorpusluteuminvolvesitcaspaseit8andisdefectiveinitcaspaseit3deficientmice |
_version_ |
1725268435049381888 |